1. Single versus tandem high‐dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long‐term results from the phase III GMMG‐HD2 trial. (17th March 2016) Authors: Mai, Elias K.; Benner, Axel; Bertsch, Uta; Brossart, Peter; Hänel, Annette; Kunzmann, Volker; Naumann, Ralph; Neben, Kai; Egerer, Gerlinde; Ho, Anthony D.; Hillengass, Jens; Raab, Marc S.; Neubauer, Andreas; Peyn, Astrid; Ko, Yon‐Dschun; Peter, Norma; Scheid, Christof; Goldschmidt, Hartmut Journal: British journal of haematology Issue: Volume 173:Number 5(2016) Page Start: 731 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network. Issue 10044 (6th August 2016) Authors: Hermine, Olivier; Hoster, Eva; Walewski, Jan; Bosly, André; Stilgenbauer, Stephan; Thieblemont, Catherine; Szymczyk, Michal; Bouabdallah, Reda; Kneba, Michael; Hallek, Michael; Salles, Gilles; Feugier, Pierre; Ribrag, Vincent; Birkmann, Josef; Forstpointner, Roswitha; Haioun, Corinne; Hänel, Math... Journal: Lancet Issue: Volume 388:Issue 10044(2016) Page Start: 565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B‐cell lymphoma: mature results of a phase II multicentre study. (28th December 2014) Authors: Kirschey, Sebastian; Flohr, Thomas; Wolf, Hans H.; Frickhofen, Norbert; Gramatzki, Martin; Link, Hartmut; Basara, Nadezda; Peter, Norma; Meyer, Ralf G.; Schmitz, Norbert; Weidmann, Eckhart; Banat, Andre; Schulz, Andrea; Kolbe, Karin; Derigs, Guenter; Theobald, Matthias; Hess, Georg Journal: British journal of haematology Issue: Volume 168:Number 6(2015:Mar.) Page Start: 824 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B‐cell lymphoma: mature results of a phase II multicentre study. (28th December 2014) Authors: Kirschey, Sebastian; Flohr, Thomas; Wolf, Hans H.; Frickhofen, Norbert; Gramatzki, Martin; Link, Hartmut; Basara, Nadezda; Peter, Norma; Meyer, Ralf G.; Schmitz, Norbert; Weidmann, Eckhart; Banat, Andre; Schulz, Andrea; Kolbe, Karin; Derigs, Guenter; Theobald, Matthias; Hess, Georg Journal: British journal of haematology Issue: Volume 168:Number 6(2015:Mar.) Page Start: 824 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗